slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,3 CNY | +1,20% | +4,38% | -21,65% |
Vakgebied
Aantal werknemers: 447
Verkoop per activiteit
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Snakegourd Skin Injections
39,2
%
| 332 | 45,8 % | 336 | 39,2 % | +1,19% |
Miglitol Tablets
38,0
%
| 190 | 26,2 % | 326 | 38,0 % | +71,43% |
Others
8,0
%
| 66 | 9,1 % | 68 | 8,0 % | +2,80% |
Carbetocin Injection
6,6
%
| 65 | 9,0 % | 57 | 6,6 % | -12,85% |
Hongjin Jiejie Tablets
6,2
%
| 41 | 5,7 % | 53 | 6,2 % | +29,73% |
Nalmefene Hydrochloride Injection
1,9
%
| 31 | 4,2 % | 17 | 1,9 % | -46,01% |
Verkoop per regio
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 725 | 100,0 % | 857 | 100,0 % | +18,10% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ke Xu
CEO | Chief Executive Officer | 46 | 01-01-10 |
Min Zhou
DFI | Director of Finance/CFO | 37 | 01-02-23 |
Ling Li
CHM | Chairman | 55 | 01-10-20 |
Yu Zhang
BRD | Director/Board Member | 44 | 01-01-05 |
Zhan Zhou
BRD | Director/Board Member | 55 | 12-12-14 |
Qian Jin Li
IRC | Investor Relations Contact | 47 | 01-06-04 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ming Hu
BRD | Director/Board Member | 53 | 13-09-21 |
Zhan Zhou
BRD | Director/Board Member | 55 | 12-12-14 |
Qian Jin Li
IRC | Investor Relations Contact | 47 | 01-06-04 |
Ke Xu
CEO | Chief Executive Officer | 46 | 01-01-10 |
Xing Gang Xiao
BRD | Director/Board Member | 50 | 13-09-21 |
Yu Zhang
BRD | Director/Board Member | 44 | 01-01-05 |
Li Ting Zhao
BRD | Director/Board Member | 42 | 31-03-23 |
Ling Li
CHM | Chairman | 55 | 01-10-20 |
Lan Feng
BRD | Director/Board Member | 46 | 13-09-21 |
Min Zhou
DFI | Director of Finance/CFO | 37 | 01-02-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 190 677 750 | 118 518 598 ( 62,16 %) | 4 000 000 ( 2,098 %) | 62,16 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,65% | 243 mln. | |
+33,43% | 690 mld. | |
+26,43% | 546 mld. | |
-5,12% | 358 mld. | |
+19,59% | 323 mld. | |
+4,89% | 287 mld. | |
+14,32% | 235 mld. | |
+5,79% | 199 mld. | |
-9,49% | 195 mld. | |
+4,26% | 161 mld. |
- Beurs
- Aandelen
- Koers 002826
- Onderneming Tibet AIM Pharm. Inc.